301 related articles for article (PubMed ID: 34666923)
21. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
PeerJ; 2023; 11():e15080. PubMed ID: 38130922
[TBL] [Abstract][Full Text] [Related]
22. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
[TBL] [Abstract][Full Text] [Related]
23. Do hydrogen peroxide mouthwashes have a virucidal effect? A systematic review.
Ortega KL; Rech BO; El Haje GLC; Gallo CB; Pérez-Sayáns M; Braz-Silva PH
J Hosp Infect; 2020 Dec; 106(4):657-662. PubMed ID: 33058941
[TBL] [Abstract][Full Text] [Related]
24. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
Benson KM; Mancini AA; Brodeur MR
Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
[TBL] [Abstract][Full Text] [Related]
25. In vitro studies evaluating the efficacy of mouth rinses on Sars-Cov-2: A systematic review.
Tadakamadla J; Boccalari E; Rathore V; Dolci C; Tartaglia GM; Tadakamadla SK
J Infect Public Health; 2021 Sep; 14(9):1179-1185. PubMed ID: 34399189
[TBL] [Abstract][Full Text] [Related]
26. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
[TBL] [Abstract][Full Text] [Related]
27. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
[TBL] [Abstract][Full Text] [Related]
28. Use of mouthwashes against COVID-19 in dentistry.
Vergara-Buenaventura A; Castro-Ruiz C
Br J Oral Maxillofac Surg; 2020 Oct; 58(8):924-927. PubMed ID: 32859459
[TBL] [Abstract][Full Text] [Related]
29. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of mouthwashes in reducing SARS-CoV-2 viral loads in human saliva: A systematic review.
Ziaeefar P; Bostanghadiri N; Yousefzadeh P; Gabbay J; Shahidi Bonjar AH; Ghazizadeh Ahsaie M; Centis R; Sabeti M; Sotgiu G; Migliori GB; Nasiri MJ
New Microbes New Infect; 2022; 49():101064. PubMed ID: 36530834
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis.
Lin SY; Sun JS; Hung MC; Chang JZ
J Hosp Infect; 2023 Sep; 139():175-191. PubMed ID: 37419189
[TBL] [Abstract][Full Text] [Related]
32. Virucidal activity of oral care products against SARS-CoV-2
Komine A; Yamaguchi E; Okamoto N; Yamamoto K
J Oral Maxillofac Surg Med Pathol; 2021 Jul; 33(4):475-477. PubMed ID: 33643836
[TBL] [Abstract][Full Text] [Related]
33. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.
Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN
Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
35. Povidone-Iodine Solution: A Potential Antiseptic to Minimize the Risk of COVID-19? A Narrative Review.
Castro-Ruiz C; Vergara-Buenaventura A
J Int Soc Prev Community Dent; 2020; 10(6):681-685. PubMed ID: 33437699
[TBL] [Abstract][Full Text] [Related]
36. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
Eduardo FP; Corrêa L; Heller D; Daep CA; Benitez C; Malheiros Z; Stewart B; Ryan M; Machado CM; Hamerschlak N; Rebello Pinho JR; Bezinelli LM
Heliyon; 2021 Jun; 7(6):e07346. PubMed ID: 34189331
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
[TBL] [Abstract][Full Text] [Related]
38. Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2.
Takeda R; Sawa H; Sasaki M; Orba Y; Maishi N; Tsumita T; Ushijima N; Hida Y; Sano H; Kitagawa Y; Hida K
Sci Rep; 2022 Aug; 12(1):14050. PubMed ID: 35982118
[TBL] [Abstract][Full Text] [Related]
39. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection.
O'Donnell VB; Thomas D; Stanton R; Maillard JY; Murphy RC; Jones SA; Humphreys I; Wakelam MJO; Fegan C; Wise MP; Bosch A; Sattar SA
Function (Oxf); 2020; 1(1):zqaa002. PubMed ID: 33215159
[TBL] [Abstract][Full Text] [Related]
40. A critical appraisal of evidence in the use of preprocedural mouthwash to avoid SARS-CoV-2 transmission during oral interventions.
Sette-de-Souza PH; Soares Martins JC; Martins-de-Barros AV; Rodrigues Vieira B; Fernandes Costa MJ; da Costa Araújo FA
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10222-10224. PubMed ID: 33090432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
